Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced that BOT/BAL will be featured in two presentations at the upcoming American Association for Cancer Research (AACR) IO Annual ...

U.S. Food and Drug Administration (FDA) recently accepted the Biologics License Application (BLA) for RP1 plus nivolumab in advanced melanoma for ...

Researchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment ...

Innate Pharma (NASDAQ:IPHA – Get Free Report) and Agenus (NASDAQ:AGEN – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based ...

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...

Channel 4 is under fire for 'sanitising' the extremist views of a woman accused of anti-Semitism and homophobia in a show about immigration. Former The Apprentice candidate Bushra Shaikh appears ...

German conservatives caused outrage by relying on the far right to try to push through the bill through parliament. The Bundestag has narrowly rejected a bill to limit migration and close Germany ...

Morgan Stanley downgraded Adagene (ADAG) to Equal Weight from Overweight with no price target While the firm believes anti-CTLA-4 approaches ...

The term 4×4 means a four-wheel-drive vehicle. Technically, the first digit is the number of wheels and the second is the number that are driven, so a four-wheel-drive pickup truck is a 4×4 ...

From its inception, the anti-vaccine movement has been intertwined with a range of political, moral, and spiritual ideas around the rights of the individual versus the community, the limits of ...

This Phase 1 study evaluated the safety and efficacy of botensilimab (BOT), an Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), an anti-PD-1 antibody, in this challenging p ...